The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice
Effects of chronic cycloprolylglycine (CPG) and its analogues GZK-001 and GZK-002 treatment at the doses 1 and 2 mg/kg on levels of monoamines and their metabolites in BALB/c mice brain were determined by HPLC. Neurochemical data demonstrated that antidepressant-like effects of the peptides are medi...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
LLC “Publisher OKI”
2020-07-01
|
| Series: | Фармакокинетика и Фармакодинамика |
| Subjects: | |
| Online Access: | https://www.pharmacokinetica.ru/jour/article/view/233 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849345349260410880 |
|---|---|
| author | A. A. Abdullina E. V. Vasileva V. S. Kudrin V. B Narkevich T. A. Gudasheva K. N. Kolyasnikova G. I. Kovalev |
| author_facet | A. A. Abdullina E. V. Vasileva V. S. Kudrin V. B Narkevich T. A. Gudasheva K. N. Kolyasnikova G. I. Kovalev |
| author_sort | A. A. Abdullina |
| collection | DOAJ |
| description | Effects of chronic cycloprolylglycine (CPG) and its analogues GZK-001 and GZK-002 treatment at the doses 1 and 2 mg/kg on levels of monoamines and their metabolites in BALB/c mice brain were determined by HPLC. Neurochemical data demonstrated that antidepressant-like effects of the peptides are mediated by an increase in NA and decrease in DA content in frontal cortex. Alterations in striatal monoamine metabolism were observed predominantly after CPG's analogues treatment: the concentration of DA was increased, although its rate of turnover was diminished. In hippocampus more active was CPG: the levels of NE, DA, 5-HT, and its metabolite 5-HIAA were decreased. GZK-001 (1 mg/kg) caused a decrease in the concentration of DA and 5-HIAA. The present results suggest that antidepressant-like effects of CPG and its analogues are associated with DA, NE, and 5-HT systems. |
| format | Article |
| id | doaj-art-914ecee0968d48a68f6126a699bf813d |
| institution | Kabale University |
| issn | 2587-7836 2686-8830 |
| language | Russian |
| publishDate | 2020-07-01 |
| publisher | LLC “Publisher OKI” |
| record_format | Article |
| series | Фармакокинетика и Фармакодинамика |
| spelling | doaj-art-914ecee0968d48a68f6126a699bf813d2025-08-20T03:42:30ZrusLLC “Publisher OKI”Фармакокинетика и Фармакодинамика2587-78362686-88302020-07-010131010.37489/2587-7836-2020-1-3-10230The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c miceA. A. Abdullina0E. V. Vasileva1V. S. Kudrin2V. B Narkevich3T. A. Gudasheva4K. N. Kolyasnikova5G. I. Kovalev6FSBI Zakusov Institute of PharmacologyFSBI Zakusov Institute of PharmacologyFSBI Zakusov Institute of PharmacologyFSBI Zakusov Institute of PharmacologyFSBI Zakusov Institute of PharmacologyFSBI Zakusov Institute of PharmacologyFSBI Zakusov Institute of PharmacologyEffects of chronic cycloprolylglycine (CPG) and its analogues GZK-001 and GZK-002 treatment at the doses 1 and 2 mg/kg on levels of monoamines and their metabolites in BALB/c mice brain were determined by HPLC. Neurochemical data demonstrated that antidepressant-like effects of the peptides are mediated by an increase in NA and decrease in DA content in frontal cortex. Alterations in striatal monoamine metabolism were observed predominantly after CPG's analogues treatment: the concentration of DA was increased, although its rate of turnover was diminished. In hippocampus more active was CPG: the levels of NE, DA, 5-HT, and its metabolite 5-HIAA were decreased. GZK-001 (1 mg/kg) caused a decrease in the concentration of DA and 5-HIAA. The present results suggest that antidepressant-like effects of CPG and its analogues are associated with DA, NE, and 5-HT systems.https://www.pharmacokinetica.ru/jour/article/view/233cycloprolylglycinegzk-001gzk-002monoaminesfrontal cortexstriatumhippocampusantidepressant-like activitybalb/c |
| spellingShingle | A. A. Abdullina E. V. Vasileva V. S. Kudrin V. B Narkevich T. A. Gudasheva K. N. Kolyasnikova G. I. Kovalev The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice Фармакокинетика и Фармакодинамика cycloprolylglycine gzk-001 gzk-002 monoamines frontal cortex striatum hippocampus antidepressant-like activity balb/c |
| title | The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice |
| title_full | The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice |
| title_fullStr | The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice |
| title_full_unstemmed | The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice |
| title_short | The effects of cycloprolylglycine and its analogues on brain monoaminergic systems in BALB/c mice |
| title_sort | effects of cycloprolylglycine and its analogues on brain monoaminergic systems in balb c mice |
| topic | cycloprolylglycine gzk-001 gzk-002 monoamines frontal cortex striatum hippocampus antidepressant-like activity balb/c |
| url | https://www.pharmacokinetica.ru/jour/article/view/233 |
| work_keys_str_mv | AT aaabdullina theeffectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT evvasileva theeffectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT vskudrin theeffectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT vbnarkevich theeffectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT tagudasheva theeffectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT knkolyasnikova theeffectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT gikovalev theeffectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT aaabdullina effectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT evvasileva effectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT vskudrin effectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT vbnarkevich effectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT tagudasheva effectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT knkolyasnikova effectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice AT gikovalev effectsofcycloprolylglycineanditsanaloguesonbrainmonoaminergicsystemsinbalbcmice |